A. Siegemund

1.6k total citations
46 papers, 1.1k citations indexed

About

A. Siegemund is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Siegemund has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 13 papers in Internal Medicine and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Siegemund's work include Blood Coagulation and Thrombosis Mechanisms (24 papers), Hemophilia Treatment and Research (13 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). A. Siegemund is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (24 papers), Hemophilia Treatment and Research (13 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). A. Siegemund collaborates with scholars based in Germany, United Kingdom and United States. A. Siegemund's co-authors include T. Siegemund, Michael Zimmermann, Andreas Raabe, Rüdiger Gerlach, Sirak Petros, Fabian Tölle, Volker Seifert, Lothar Engelmann, Mario Koksch and Ute Scholz and has published in prestigious journals such as Stroke, Neurosurgery and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

A. Siegemund

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Siegemund Germany 20 596 269 264 193 173 46 1.1k
Scott Dunkley Australia 18 528 0.9× 218 0.8× 118 0.4× 201 1.0× 65 0.4× 51 935
U. Martinowitz Israel 22 1.1k 1.8× 119 0.4× 141 0.5× 194 1.0× 86 0.5× 53 1.5k
Shu He Sweden 20 555 0.9× 316 1.2× 250 0.9× 122 0.6× 363 2.1× 42 1.1k
Françoise Bridey France 15 711 1.2× 257 1.0× 382 1.4× 494 2.6× 82 0.5× 36 1.2k
Karin Strandberg Sweden 19 507 0.9× 726 2.7× 615 2.3× 232 1.2× 197 1.1× 72 1.4k
C. P. Henny Netherlands 17 303 0.5× 206 0.8× 98 0.4× 305 1.6× 129 0.7× 31 1.1k
G.D.O. Lowe United Kingdom 17 365 0.6× 444 1.7× 285 1.1× 276 1.4× 396 2.3× 61 1.4k
Yoo Goo Kang United States 12 144 0.2× 142 0.5× 101 0.4× 515 2.7× 232 1.3× 16 1.2k
Steven E. Hill United States 16 149 0.3× 329 1.2× 88 0.3× 666 3.5× 157 0.9× 32 1.5k
Douglas Martin United States 11 126 0.2× 109 0.4× 92 0.3× 759 3.9× 190 1.1× 22 1.3k

Countries citing papers authored by A. Siegemund

Since Specialization
Citations

This map shows the geographic impact of A. Siegemund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Siegemund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Siegemund more than expected).

Fields of papers citing papers by A. Siegemund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Siegemund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Siegemund. The network helps show where A. Siegemund may publish in the future.

Co-authorship network of co-authors of A. Siegemund

This figure shows the co-authorship network connecting the top 25 collaborators of A. Siegemund. A scholar is included among the top collaborators of A. Siegemund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Siegemund. A. Siegemund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stöbe, Stephan, T. Siegemund, A. Siegemund, et al.. (2024). Detection of direct oral anticoagulants with the diluted Russel's viper venom time. International Journal of Laboratory Hematology. 46(5). 927–935.
2.
Pfrepper, Christian, et al.. (2023). Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients. Research and Practice in Thrombosis and Haemostasis. 7(2). 100054–100054. 3 indexed citations
3.
Pfrepper, Christian, et al.. (2021). Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA. International Journal of Laboratory Hematology. 44(1). 193–201. 5 indexed citations
4.
Pfrepper, Christian, et al.. (2020). Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system. Research and Practice in Thrombosis and Haemostasis. 4(4). 619–627. 21 indexed citations
5.
Tripodi, Armando, Veena Chantarangkul, Michela Cini, et al.. (2017). Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study. Journal of Thrombosis and Haemostasis. 15(6). 1180–1190. 23 indexed citations
6.
Schobeß, R., et al.. (2014). Clot waveform analysis in patients with haemophilia A. Hämostaseologie. 34(S 01). S48–S62. 22 indexed citations
7.
Engelmann, L., et al.. (2008). Thrombolyse einer ausgedehnten Venenthrombose der unteren Körperhälfte bei Anomalie der Vena cava inferior. DMW - Deutsche Medizinische Wochenschrift. 121(5). 124–128. 3 indexed citations
8.
Dargaud, Yesim, Elaine Gray, Claude Négrier, et al.. (2007). Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. British Journal of Haematology. 139(2). 303–309. 105 indexed citations
9.
Siegemund, A., et al.. (2006). Evaluation of the pharmacokinetics of dalteparin in patients with renal insufficiency. International Journal of Clinical Pharmacology and Therapeutics. 44(10). 455–465. 15 indexed citations
10.
Lohmann, Tobias, Anna Kobsar, A. Siegemund, et al.. (2006). Enhanced platelet activation by prolactin in patients with ischemic stroke. Thrombosis and Haemostasis. 96(7). 38–44. 47 indexed citations
11.
Petros, Sirak, T. Siegemund, A. Siegemund, & Lothar Engelmann. (2006). The effect of different anticoagulants on thrombin generation. Blood Coagulation & Fibrinolysis. 17(2). 131–137. 19 indexed citations
12.
Bassus, S., A. Siegemund, Sirak Petros, et al.. (2006). Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A. Platelets. 17(6). 378–384. 18 indexed citations
13.
Berrouschot, Jörg, et al.. (2005). Aspirin resistance in secondary stroke prevention. Acta Neurologica Scandinavica. 113(1). 31–35. 53 indexed citations
14.
Siegemund, A., Sirak Petros, T. Siegemund, et al.. (2004). The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI. Blood Coagulation & Fibrinolysis. 15(3). 241–244. 27 indexed citations
15.
Siegemund, T., A. Siegemund, Ute Scholz, Lothar Engelmann, & Sirak Petros. (2003). Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma. Thrombosis and Haemostasis. 90(11). 781–786. 60 indexed citations
16.
Grünewald, Martin, et al.. (2003). Plasmatic coagulation and fibrinolytic system alterations in PNH. Blood Coagulation & Fibrinolysis. 14(7). 685–695. 31 indexed citations
17.
18.
Koksch, Mario, et al.. (2001). Coagulation, Fibrinolysis and Platelet P-selectin Expression in Peripheral Vascular Disease. European Journal of Vascular and Endovascular Surgery. 21(2). 147–154. 32 indexed citations
19.
Maly, Friedrich E., A. von Felten, A. Siegemund, et al.. (2001). Genetic Predisposition to Bleeding during Oral Anticoagulant Therapy: Evidence for Common Founder Mutations (FIXVal-10 and FIXThr-10) and an Independent CpG Hotspot Mutation (FIXThr-10). Thrombosis and Haemostasis. 85(3). 454–457. 13 indexed citations
20.
Gerlach, Rüdiger, et al.. (2000). Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surgical Neurology. 54(3). 260–266. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Dunkley Breakdown of academic impact, for papers by U. Martinowitz Breakdown of academic impact, for papers by Shu He Breakdown of academic impact, for papers by Françoise Bridey Breakdown of academic impact, for papers by Karin Strandberg Breakdown of academic impact, for papers by C. P. Henny Breakdown of academic impact, for papers by G.D.O. Lowe Breakdown of academic impact, for papers by Yoo Goo Kang Breakdown of academic impact, for papers by Steven E. Hill Breakdown of academic impact, for papers by Douglas Martin
Rankless by CCL
2026